• CDK4/6 and BET Inhibitor Synergy in Pancreatic Cancer Suppre

  2026-07-06

  Gu et al. (2025) reveal that combining CDK4/6 and BET inhibitors leads to synergistic suppression of pancreatic ductal adenocarcinoma (PDAC) growth and epithelial-to-mesenchymal transition (EMT) by modulating GSK3β-mediated Wnt/β-catenin signaling. This work clarifies the limitations of CDK4/6 monotherapy and provides a mechanistic rationale for combination strategies in aggressive PDAC.

• RP3-340N1.2 Knockdown Destabilizes IL-6 and Suppresses NSCLC

  2026-07-06

  This study reveals that the long non-coding RNA RP3-340N1.2 promotes non-small cell lung cancer (NSCLC) by stabilizing IL-6 mRNA, thus enhancing tumor proliferation and migration. Knockdown of RP3-340N1.2 enhances IL-6 mRNA degradation via increased interaction with the RNA-binding protein ZC3H12A, highlighting a novel lncRNA-mediated regulatory pathway with translational potential for transcriptional regulation research.

• G-15: Advancing Precision GPR30 Antagonism in Estrogen Resea

  2026-07-05

  Explore how G-15, a selective G protein-coupled estrogen receptor antagonist, redefines estrogen signaling research through rigorous mechanistic insight and practical assay guidance. This article uniquely dissects its application in calcium mobilization and PI3K/Akt pathway modulation.

• Safe DNA Gel Stain (SKU A8743): Reliable Visualization for M

  2026-07-04

  This article addresses real-world laboratory challenges in nucleic acid visualization and demonstrates how Safe DNA Gel Stain (SKU A8743) provides reproducible, less mutagenic, and user-friendly solutions. Integrating scenario-based Q&A, it highlights practical advantages—such as high sensitivity, improved safety, and cloning efficiency—making it a credible choice for advanced molecular biology and cell-based assay workflows.

• 3X (DYKDDDDK) Peptide: Reliable Tagging for Protein Assays

  2026-07-03

  This article explores how the 3X (DYKDDDDK) Peptide (SKU A6001) addresses common experimental pain points in cell viability, proliferation, and cytotoxicity assays. Scenario-driven Q&A blocks demonstrate its reliability, sensitivity, and workflow compatibility, supporting researchers in robust affinity purification, immunodetection, and structural protein studies.

• Polyploid Giant Cancer Macrophages: Prognostic Role in Circu

  2026-07-03

  This study identifies circulating polyploid giant cancer macrophages (CAMLs) as robust indicators of disease progression in various solid tumors. By characterizing their phenotype and association with metastatic niche formation, the research highlights new avenues for monitoring and potentially modulating early cancer dissemination.

• Injectable GelMA/QCS/Ca2+ Adhesive: Hemostasis and Infection

  2026-07-02

  This study introduces a photo-crosslinkable, injectable adhesive based on gelatin methacryloyl (GelMA), quaternary ammonium chitosan (QCS), and calcium ions for rapid hemostasis and antibacterial protection in non-compressible wounds. The adhesive demonstrates superior sealing, biocompatibility, and infection control compared to conventional fibrin glue, highlighting its potential for emergency and battlefield applications.

• ARCA Cy5 EGFP mRNA (5-moUTP): Fluorescent mRNA Delivery Benc

  2026-07-02

  ARCA Cy5 EGFP mRNA (5-moUTP) is a 5-methoxyuridine modified, fluorescently labeled mRNA that enables direct, quantitative analysis of mRNA delivery, localization, and translation efficiency in mammalian cells. Its dual-label design streamlines workflow for high-content microscopy and flow cytometry, while modifications suppress innate immune activation and boost stability.

• Dorsomorphin 2HCl: Precision AMPK Inhibition in Metabolic Re

  2026-07-01

  Dorsomorphin 2HCl empowers researchers to dissect metabolic and bone morphogenetic pathways with reproducible precision, uniquely enabling advanced models of lipid metabolism and osteogenesis. Recent breakthroughs clarify its value in linking AMPK inhibition to gut-liver axis studies, supporting innovation from cellular assays to in vivo models.

• Nocodazole (SKU A8487): Reliable Microtubule Polymerization

  2026-07-01

  This article provides scenario-driven, evidence-based guidance for biomedical researchers and laboratory technicians using Nocodazole (SKU A8487) in cell cycle, viability, and cytotoxicity assays. Drawing on validated protocols, recent literature, and real-world lab challenges, it demonstrates how Nocodazole’s precise, reversible tubulin inhibition supports reproducible microtubule dynamics research and robust anticancer drug evaluation.

• Phosphatase Inhibitor Cocktail 1: Elevating Phosphorylation

  2026-06-30

  Explore how Phosphatase Inhibitor Cocktail 1 (100X in DMSO) safeguards protein phosphorylation states for advanced phosphoproteomic analysis. This in-depth guide uniquely connects molecular preservation to translational research outcomes.

• Cell Counting Kit-8 Plus: Precision Tetrazolium Salt Assay A

  2026-06-30

  The Cell Counting Kit-8 (CCK-8) Plus harnesses advanced WST-8 chemistry for rapid, highly sensitive cell proliferation and cytotoxicity assays. Its broad detection range and speed empower drug screening and mechanistic cellular research, as highlighted in recent senolytic studies and cross-disciplinary workflows.

• Puromycin dihydrochloride: Precision Selection and Translati

  2026-06-29

  Puromycin dihydrochloride stands out as an aminonucleoside antibiotic for rigorous cell selection and real-time translation process studies. With defined protocol parameters and robust troubleshooting, this compound enables high-fidelity workflows for both stable cell line selection and advanced mechanistic research.

• Aconitase Assays: Empowering Translational Metabolic Researc

  2026-06-29

  Explore how the Aconitase Activity Colorimetric Assay Kit, rooted in iron-sulfur protein aconitase biology, is revolutionizing translational immunometabolism. This article integrates mechanistic insights, experimental strategies, and clinical relevance—drawing from recent discoveries on T-cell metabolic flexibility and oxidative damage measurement—to guide researchers seeking actionable, high-impact data.

• Intracellular Action of Aminopeptidase Inhibitors in Myeloma

  2026-06-28

  This study demonstrates that bestatin and actinonin inhibit myeloma cell proliferation primarily via intracellular mechanisms rather than cell surface aminopeptidase inhibition. The findings inform targeted research strategies for overcoming multidrug resistance and optimizing apoptosis induction in myeloma models.

15728 records 1/1049 page Next 12345 下5页 Last page